secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2022-03-21T23:59:59+00:00
Accession:  0001625101-22-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences EVP & GM of Dermatology Ed Ebbers resigns; position eliminated
--------------------------------------------------------------------------------

- Ed Ebbers resigned as EVP & GM of Dermatology effective March 18, 2022; role eliminated in streamlining effort.
- Severance includes six months' base salary in 12 semi-monthly installments, plus $28,318 in lieu of 2022 cash bonus.
- Unvested equity awards accelerating over 12 months from separation date; COBRA health benefits continued.
- Company expects to enter a consulting arrangement with Ebbers for a smooth transition.
- Resignation not related to any disagreement over operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/0001625101-22-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/plse-20220318x8k.htm
  HTML page:      https://secwatch.observer/filing/0001625101-22-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer